Current Rating and Its Significance
On 03 August 2026, National Peroxide Ltd’s rating was revised from 'Sell' to 'Hold' by MarketsMOJO, reflecting a notable improvement in its overall Mojo Score, which rose by 16 points from 40 to 56. This 'Hold' rating suggests that the stock currently offers a balanced risk-reward profile, indicating neither a strong buy nor a sell recommendation. Investors should interpret this as a signal to maintain existing positions or consider cautious accumulation, depending on their portfolio strategy and risk appetite.
Here’s How the Stock Looks Today
As of 22 September 2026, National Peroxide Ltd demonstrates a mixed but cautiously optimistic outlook across key evaluation parameters. The company operates within the Commodity Chemicals sector and is classified as a microcap stock, which often entails higher volatility but also potential for growth.
Quality Assessment
The quality grade for National Peroxide Ltd is below average, reflecting some challenges in its long-term fundamental strength. The company has experienced a compound annual growth rate (CAGR) of -1.79% in operating profits over the past five years, signalling a contraction in core earnings. Additionally, the average Return on Equity (ROE) stands at a modest 2.75%, indicating limited profitability relative to shareholders’ funds. These factors suggest that while the company is operationally stable, it faces headwinds in generating robust returns on invested capital.
Valuation Perspective
Despite the quality concerns, the valuation grade is attractive. Currently, the stock trades at a Price to Book (P/B) ratio of 0.9, which is below the average historical valuations of its peers in the sector. This discount implies that the market is pricing in some of the company’s challenges, potentially offering value for investors willing to look beyond short-term fluctuations. The Return on Equity has improved to 5.1% recently, supporting the notion that the company is beginning to generate better returns. Furthermore, the Price/Earnings to Growth (PEG) ratio is an exceptionally low 0.1, signalling that the stock’s price is low relative to its earnings growth potential.
Financial Trend and Recent Performance
The financial grade is very positive, reflecting encouraging recent results. The latest quarterly data shows net sales reaching a record high of ₹96.07 crores, with profit before tax (PBT) excluding other income at ₹6.70 crores, representing a 196.5% growth compared to the previous four-quarter average. Net profit after tax (PAT) also rose significantly by 104.6% to ₹6.61 crores. The company has reported positive results for three consecutive quarters, indicating a stabilising and improving financial trajectory. Over the past six months, the stock has delivered a strong return of +49.65%, while the year-to-date return stands at +27.35%. However, the one-year return remains slightly negative at -2.00%, reflecting some volatility in the longer term.
Technical Outlook
The technical grade is mildly bullish, supported by recent price movements and momentum indicators. The stock gained 2.76% on the latest trading day, signalling positive investor sentiment. While short-term fluctuations have included minor declines over one week (-1.61%) and one month (-3.91%), the three-month performance shows a 5.11% gain, reinforcing a cautiously optimistic technical stance. This mild bullishness suggests that the stock may continue to experience moderate upward momentum, but investors should remain vigilant for potential volatility given its microcap status.
Ownership and Market Capitalisation
National Peroxide Ltd is majority-owned by promoters, which often provides stability in corporate governance and strategic direction. The company’s microcap market capitalisation reflects its relatively small size within the Commodity Chemicals sector, which can offer growth opportunities but also entails higher risk compared to larger peers.
Strong fundamentals, steady climb upward! This Large Cap from Telecommunication sector earned its Reliable Performer badge through consistent execution. Safety meets solid returns here!
- - Reliable Performer certified
- - Consistent execution proven
- - Large Cap safety pick
What the Hold Rating Means for Investors
The 'Hold' rating assigned to National Peroxide Ltd indicates that the stock currently presents a balanced investment proposition. Investors should recognise that while the company’s fundamentals have some weaknesses, particularly in long-term profitability and quality metrics, its attractive valuation and improving financial trends provide a cushion against downside risks. The mildly bullish technical outlook further supports a neutral stance, suggesting that the stock may offer moderate gains but is unlikely to deliver outsized returns in the near term.
For investors, this means maintaining existing holdings could be prudent, especially for those with a medium to long-term horizon who are comfortable with microcap volatility. New investors might consider accumulating shares gradually, taking advantage of the stock’s attractive valuation, but should remain cautious and monitor quarterly results closely for sustained improvement in quality and profitability.
Summary of Key Metrics as of 22 September 2026
• Mojo Score: 56.0 (Hold grade)
• Operating Profit CAGR (5 years): -1.79%
• Average ROE: 2.75% (improving to 5.1%)
• Price to Book Value: 0.9
• PEG Ratio: 0.1
• Latest Quarterly Net Sales: ₹96.07 crores
• Quarterly PBT (excl. other income): ₹6.70 crores (growth of 196.5%)
• Quarterly PAT: ₹6.61 crores (growth of 104.6%)
• Stock Returns: 1D +2.76%, 6M +49.65%, YTD +27.35%, 1Y -2.00%
These figures highlight a company that is navigating challenges but showing signs of financial resilience and value potential. Investors should weigh these factors carefully within the context of their portfolio objectives and risk tolerance.
Outlook and Considerations
Looking ahead, National Peroxide Ltd’s ability to sustain its recent profit growth and improve operational efficiency will be critical to upgrading its quality grade and potentially moving towards a more favourable rating. The attractive valuation offers a margin of safety, but investors should remain alert to sector dynamics and broader market conditions that could impact the commodity chemicals industry.
In conclusion, the 'Hold' rating reflects a nuanced view that balances current financial strength and valuation appeal against ongoing quality concerns. This measured stance encourages investors to stay informed and consider the stock as part of a diversified portfolio rather than a high-conviction buy at this stage.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
